New York, April 22, 2021 (GLOBE NEWSWIRE) – Reportlinker.com Announces the Release of the “Global Magnetic Beads Market By Magnetism, By Size, By Application, By Regional Outlook, Industry Analysis Report And Forecast, 2020-2026 “- https://www.reportlinker.com/p06064808/?utm_source=GNW
They do not attract each other when not in the magnetic field, which is why they can be easily used without any unwanted agglutination stress. The separation of magnetic beads is a fast, efficient and clear process that is used by scientists to replace their filtration, centrifugation and separation methods. Beads and magnetic elements are used with antibodies, antigens, proteins, catalysts or nucleic acids, which allows them to bind together cells, viruses, bacteria and other biological organisms.
They are used to provide a reliable and simplified technique for refining various types of biomolecules, such as genomic DNA, plasmids, proteins, mitochondrial DNA and RNA. The growing trend of protein sample preparation and protein purification will open new growth avenues for the magnetic beads market. Factors such as changing preferences for in vitro diagnostic testing, technological improvements in magnetic beads, and increasing healthcare spending are expected to drive the growth of the magnetic beads market during the forecast period.
Along with this, the major market players are emphasizing the introduction of various new, advanced, innovative and effective magnetic beads which will drive the market demand. In addition, the COVID-19 pandemic has had a positive impact on the magnetic beads market as they are considered the basic tool for research laboratories, due to which they have seen an increase in their use.
Perspectives of magnetism
Based on magnetism, the market is segmented into ferrimagnetic and superparamagnetic. The ferrimagnetic market dominated the global magnetism magnetic balls market in 2019. The superparamagnetic market is expected to experience a CAGR of 14.1% during the period (2020-2026).
Based on the size, the market is segmented into less than 5 Âµm, 5-20 Âµm, 20-40 Âµm, and 40 Âµm and above. The less than 5 Âµm market dominated the global magnetic beads market by size in 2019, with a CAGR of 12.1% during the forecast period. The 5-20 um market exhibits a CAGR of 11.7% during (2020 – 2026). Moreover, the 20-40um market is expected to grow at a CAGR of 14.9% during the period (2020-2026).
Based on the application, the market is segmented into Next Generation Sequencing (NGS), Biomolecule Separation and Purification, Molecular and Immunological Diagnostics, and others. The biomolecule separation and purification market dominated the global magnetic beads market by application in 2019 and is expected to continue to be a dominant market until 2026. Next generation sequencing (NGS) market is expected to experience a CAGR by 11.9% during (2020 – 2026).
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and Latin America, Middle East and Africa. Europe is expected to experience a promising growth rate during the forecast period. This growth is attributed to the growing awareness of the population in health, which further stimulated the demand for diagnostics and therapeutic solutions in this region. In addition, the increasing adoption of the product for the diagnosis and treatment of many medical conditions such as cancer and brain tumors is believed to fuel demand for the product in the regional healthcare industry.
The market research report covers the analysis of the major players in the market. Major companies featured in the report include Thermo Fisher Scientific, Inc., Merck Group, Bangs Laboratories, Inc. (Polysciences, Inc.), Spherotech, Inc., Promega Corporation, Zeesan Biotech Co., Ltd., Vazyme Biotech Co. , Ltd., Magbio Genomics, Inc., Calbiotech, Inc. (Erba Diagnostics Group Ltd.) and New England BioLabs, Inc.
Strategies deployed on the magnetic beads market
February-2021: Thermo Fisher has entered into an agreement with JW Therapeutics, a leading cell therapy company. The agreement was to secure non-exclusive commercial access to Thermo Fisher Gibco CTS Dynabeads CD3 / CD28. The agreement would support the clinical development and commercial manufacture of key Chimeric Antigen Receptor T-Cells (CAR-T) therapies in China, including JW Therapeutics’ flagship product, relmacabtagene autoleucel (ârelma-celâ).
Sep-2019: Merck showcased its official flagship store (merckls.1688.com) on Alibaba’s 1688.com. The store provides convenient online sales services for Chinese customers who purchase biochemical reagents and laboratory analytical reagents.
May-2019: Thermo Fisher launched the MagMAX Ultra-Microbiome Nucleic Acid Isolation Kit, a DNA and RNA isolation kit ready for automation. The kit is a new high throughput sample processing tool. It is used in advanced microbiome research. This kit helps recover RNA and DNA from the harshest and nastiest samples used in microbiome work, such as stool and soil samples.
Jan-2018: Thermo Fisher announced seven years of CAR-T technology with Juno Therapeutics. Under the agreement, the latter company uses the former company’s Cell Therapy Systems (CTS) technology to develop CAR T therapies for the treatment of cancer.
August 2017: Merck announced an agreement to acquire Natrix Separations, a supplier of hydrogel membrane products for single-use chromatography. This acquisition would complement Merck’s efforts in driving next generation bioprocesses, ultimately enabling faster and more efficient technology for its customers.
Scope of the study
Market segments covered in the report:
â¢ Less than 5 um
â¢ 5-20 um
â¢ 20-40 um
â¢ 40 um and more
â¢ Next generation sequencing (NGS)
â¢ Separation and purification of biomolecules
â¢ Molecular and immunological diagnosis
â¢ North America
o United States
o Rest of North America
o Rest of Europe
â¢ Asia Pacific
o South Korea
o Rest of Asia-Pacific
o United Arab Emirates
o Saudi Arabia
o Rest of LAMEA
â¢ Thermo Fisher Scientific, Inc.
â¢ Merck Group
â¢ Bangs Laboratories, Inc. (Polysciences, Inc.)
â¢ Spherotech, Inc.
â¢ Promega Company
â¢ Zeesan Biotech Co., Ltd.
â¢ Vazyme Biotech Co., Ltd.
â¢ Magbio Genomics, Inc.
â¢ Calbiotech, Inc. (Erba Diagnostics Ltd. Group)
â¢ New England BioLabs, Inc.
â¢ Comprehensive coverage
â¢ The largest number of tables and figures on the market
â¢ Subscription-based model available
â¢ Best price guaranteed
â¢ After-sales research support guaranteed with 10% free customization
Read the full report: https://www.reportlinker.com/p06064808/?utm_source=GNW
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.